2008
DOI: 10.1185/03007990802522397
|View full text |Cite
|
Sign up to set email alerts
|

Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
27
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(27 citation statements)
references
References 77 publications
0
27
0
Order By: Relevance
“…Circadian rhythms are often disturbed in patients with Alzheimer's disease [6]. In addition, modulating the natural circadian fluctuations of central cholinergic transmission is an important factor for improvement when using galanthamine to stimulate central cholinergic transmission in Alzheimer's disease [36]. Here, we showed that Lycoris alkaloids also have an acetylcholinesterase inhibition activity [13] and elongate the circadian period ( Fig.…”
Section: Chronotherapeutic Insight Into Phyto-alkaloidsmentioning
confidence: 66%
“…Circadian rhythms are often disturbed in patients with Alzheimer's disease [6]. In addition, modulating the natural circadian fluctuations of central cholinergic transmission is an important factor for improvement when using galanthamine to stimulate central cholinergic transmission in Alzheimer's disease [36]. Here, we showed that Lycoris alkaloids also have an acetylcholinesterase inhibition activity [13] and elongate the circadian period ( Fig.…”
Section: Chronotherapeutic Insight Into Phyto-alkaloidsmentioning
confidence: 66%
“…Conversely, in both of our patients the appearance of neurodegenerative process was followed by a significant improvement of all narcoleptic symptoms, including EDS and cataplexy. EDS's paradoxical improvement, as already reported [17] , may be due to the overall sleep improvement and sleep-wake cycle regulation following cholinergic treatment. Interestingly, cataplexy is also mediated by the cholinergic system, and usually responds to anti-cholinergic drugs, while in our case, cataplexy was improved by an enhancement of the cholinergic system.…”
Section: Discussionmentioning
confidence: 66%
“…In addition to circadian alterations occurring with normal aging, neurodegenerative disorders associated with aging, including Alzheimer's, Parkinson's, and Huntington's diseases, are correlated with disordered circadian rhythms and disrupted sleep patterns (Hatfield et al 2004;Nieoullon et al 2008;Wulff et al 2010;Cermakian et al 2011;Videnovic et al 2014;Musiek 2015). Traditionally, circadian and sleep disorders associated with neurodegenerative diseases have been viewed as symptomatic of these diseases as circadian disorders often correlate with disease severity and rhythms deteriorate with disease progression.…”
Section: The Circadian Clock Aging and Neurodegenerative Diseasesmentioning
confidence: 99%